NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |
| Gs Investments, Inc. | 18,900 | $321,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,139,000 | 0.31% |
| Virtus ETF Advisers LLC | 34,503 | $587,000 | 0.24% |
| PRIMECAP MANAGEMENT CO/CA/ | 18,440,399 | $313,487,000 | 0.23% |
| DCF Advisers, LLC | 31,300 | $532,000 | 0.22% |
| PDT Partners, LLC | 183,799 | $3,125,000 | 0.21% |
| IEQ CAPITAL, LLC | 266,559 | $4,532,000 | 0.20% |
| LIBERTY WEALTH MANAGEMENT LLC | 19,000 | $393,000 | 0.19% |
| AdvisorNet Financial, Inc | 129,116 | $2,195,000 | 0.18% |
| Invesco Ltd. | 35,456,949 | $602,768,000 | 0.18% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q4 2020. To view NEKTAR THERAPEUTICS's shareholder history, click here.